High materiality8/10
Definium Therapeutics price target raised to $60 from $40 at Oppenheimer
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer raises DFTX price target to $60; current price around $37.95.
- Oppenheimer raises DFTX PT to $60; current price $37.95.
Key facts
- 01
Target: $60
- 02
Posted price: $37.95
- 03
Analyst firm: Oppenheimer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.